Navigation Links
UK kidney cancer patients face toxic, out-dated treatments with little hope of change
Date:12/9/2008

Leading oncologist Professor Tim Eisen has expressed concerns that patients with advanced kidney cancer could be condemned to toxic, barely effective, 20 year-old treatments because the National Institute for Health and Clinical Excellence (NICE) is likely to rule out using all four of the new treatments it has assessed.

Writing in the December issue of BJU International, Professor Eisen, from the University of Cambridge, points out that although NICE has put its findings out for consultation, its provisional decision is that sunitinib, sorafenib, temsirolimus and interferon plus bevacizumab are too costly.

A further review is due to be carried out in January 2009, but Professor Eisen fears that NICE - which advises the UK Department of Health - may confirm its provisional advice that none of these treatments should be provided by the UK's National Health Service.

"We had hoped that NICE would approve at least one of these drugs, as they represent a major breakthrough and there are no suitable alternatives for the large majority of the 4,000 or so patients who might be considered for these drugs in the UK" says Professor Eisen.

"Given that sunitinib was investigated as a first line option, it seemed most likely that it would be approved.

"Our hopes were dashed when NICE released its consultation document. It said that although the four drugs they looked at were clinically effective, they were not cost-effective."

Professor Eisen says that about one in ten patients benefit significantly from existing drugs to activate the immune system, leaving the other 90 per cent with no benefits, just a range of unpleasant side effects, including flu-like symptoms and depression.

He points out that a number of very effective treatments have been developed in the last three years, but he fears that when NICE issues its final recommendations next spring the hopes of UK clinicians and patients could be wel
'/>"/>

Contact: Annette Whibley
wizard.media@virgin.net
Wiley-Blackwell
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Vitamin B1 could reverse early-stage kidney disease in diabetes patients
2. Understanding donor-recipient genetics could decrease early kidney transplant complications
3. Special Guest Alonzo Mourning to Attend National Kidney Foundations 28th Annual Kidney Ball Featuring Entertainment by the Doobie Brothers
4. Cardiff scientists study acute infection in end-stage kidney disease patients
5. Kidney Cars Celebrates America Recycles Day
6. Genetic blueprint revealed for kidney design and formation
7. Indigenous Australian patients confused and frustrated by kidney disease
8. Tour DaVita Raises More Than $400K for Kidney Disease Awareness
9. Gene Mutation in Dalmatians Sheds Light on Kidney Stones in Humans
10. Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease
11. Cytochroma Announces Positive Comparative Data on CTA018 in Chronic Kidney Disease Model
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... the University of California, San Diego School of Medicine ... have suffered a recent major loss are more likely ... , The study is published in this month,s issue ... , Because compassionate behaviors are associated with better health ... insights into ways to improve the outcomes of individuals ...
(Date:4/17/2014)... In a review published in the April issue ... of The Feinstein Institute for Medical Research, says it,s ... community,s approach to treating sepsis, which kills ... , Sepsis occurs when molecules released into the bloodstream ... the body. Inflammation is necessary for maintaining good health ...
(Date:4/17/2014)... Northwestern University synthetic biology team has created a ... programmable therapeutics that could travel the body and ... , Engineering cell-based, biological devices that monitor and ... clinical synthetic biology. However, no existing technology enabled ... patient,s physiological state and respond in a customized ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... YORK, NY (April 16, 2014) The cause of ... a new study proposes that neurons may be mistaken ... immune system, similar to the way autoimmune diseases like ... the body,s cells. The study was published April 16, ... a new, and likely controversial, idea in Parkinson,s disease; ...
Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
... Mechanics has recognized three NSF-funded projects with innovation ... who have lost it; a system that uses "controlled ... and an inexpensive medical microscope built for cell-phones that ... cells. Those projects, along with 16 others, are ...
... system faces a challenge in overcoming communication barriers ... the University of Gothenburg, Sweden. The thesis ... refugees have found it hard to gain access ... are entitled to. Interpreters were sometimes assigned on ...
... News) -- The brains of new mothers actually get ... The researchers, most from the Yale University School of ... in levels of certain hormones just after birth. They reported ... and motivation. The researchers also found that mothers who ...
... with a type of metastatic liver cancer --hepatocellular carcinoma ... according to Penn State College of Medicine researchers. Hepatocellular ... deaths in the world. Hanning You, M.D., Ph.D., postdoctoral ... pediatrics and pharmacology, targeted c-Met, a known receptor for ...
... dangers of the traditional negative physical risk factors ... overweight. But far less research has focused on ... psychological and social supports. New research by Margie ... the Brandeis Psychology Department explores the psychological roots ...
... team of physicians and scientists from the Cedars-Sinai Regenerative Medicine ... PhD has been awarded a three-year $1.9 million grant from ... clinical trials for what could become the first biological treatment ... patients. The grant was announced ...
Cached Medicine News:Health News:Popular Mechanics breakthrough awardees announced 2Health News:Communicating through interpreters -- a challenge for health care 2Health News:New Moms' Brains May Grow After Childbirth 2Health News:Personalized treatment may help some liver cancer patients 2Health News:Positive social traits trump bad health habits 2Health News:Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis 2
(Date:1/15/2014)... , Jan. 15, 2014 Most osteoporosis patients ... to a recent online survey* sponsored by Mission Pharmacal ... the National Osteoporosis Foundation online support community, revealed that ... medication that comes in a form other than a ...
(Date:1/15/2014)... Jan. 15, 2014  Celsion Corporation (the "Company") (NASDAQ: ... from institutional investors to purchase an aggregate of approximately ... at-the-market registered direct offering, led by a dedicated health ... purchase agreements with these investors pursuant to which the ...
(Date:1/15/2014)...  Manufacturers, suppliers and distributors of innovative medical-related products ... most important business assets, intellectual property (IP). ... Because of the highly-competitive nature of the Medical ... most litigious industry sectors of cases involving IP ...
Breaking Medicine Technology:Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 2Mission Pharmacal Conducts Online Survey of Osteoporosis Patients 3Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 2Celsion Corporation Announces $15 Million At-The-Market Registered Direct Offering 3Intellectual Property Insurance for Medical-related Products and Services 2
... N.C., Feb. 10, 2012  Viztek, the digital radiology solution ... U-Arm at Edison Metuchen Orthopaedic Group (EMOG) in Edison, ... psychiatrist with onsite x-ray and access to an MRI facility ... EMOG performs between 65 and 85 x-ray procedures ...
... PRINCETON, N.J., Feb. 10, 2012 Soligenix, Inc. ... stage biopharmaceutical company, announced preliminary results today from ... time-release formulation of oral beclomethasone 17,21-dipropionate (oral BDP), ... The Phase 1/2 protocol BDP-ENT-01 was ...
Cached Medicine Technology:Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 2Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 3Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 4Soligenix Announces Results From Its Phase 1/2 Clinical Trial of SGX201 for the Prevention of Acute Radiation Enteritis 5
... with BD Xstar Blade includes a specially ... blade in prodedure and handling. The ... grind-less process for manufacturing surgical blades. ... consistency. The arch style, single-bevel geometry ...
... Knife with BD Xstar Blade includes a ... the blade in prodedure and handling. ... a grind-less process for manufacturing surgical blades. ... and consistency. The arch style, single-bevel ...
Bio-Rad's Genetic Systems HIV-1/HIV-2 PLUS O EIA is a unique assay that detects the broadest range of HIV....
An advanced microprocessor-controlled unit with superior reliability and reproducible power. Its modern electronics provides the precision and control a surgeon expects....
Medicine Products: